Profil
Gregory E.
Papaz is currently the President of Newfield Therapeutics Corp.
He was previously the President & CEO of PAION, Inc. and Senior Vice President-US Commercial Operations at Optimer Pharmaceuticals LLC.
Papaz holds an MBA from Cornell University and an undergraduate degree from Providence College.
Aktiva positioner av Gregory E. Papaz
| Företag | Position | Start |
|---|---|---|
Newfield Therapeutics Corp.
Newfield Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel diagnostic and therapeutic oncological products | President | 2018-02-01 |
Tidigare kända positioner av Gregory E. Papaz
| Företag | Position | Slut |
|---|---|---|
PAION, Inc.
PAION, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Verkställande Direktör | 2017-03-01 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products | Företagsledare/Principal | 2012-12-11 |
Gregory E. Papazs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Providence College
Providence College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products | Health Technology |
PAION, Inc.
PAION, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Newfield Therapeutics Corp.
Newfield Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel diagnostic and therapeutic oncological products | Health Technology |
















